跳至主要内容
临床试验/NCT00881335
NCT00881335已完成不适用

Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function

Tongji University0 个研究点目标入组 60 人开始时间: 2009年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
主要终点
FVC, Forced Vital Capacity

研究概览

简要总结

The purpose of this study is to evaluate the clinical outcome and safety of flutter mucus clearance devices in elders of gerocomium.

详细描述

Respiratory diseases are still increasing in the elderly population. The fluttering mucus clearance technique is expected to be a physical assisting therapy enhancing airway secretion clearance but needs more clinical randomized, controlled trial evidence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
85 Years 至 —(Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •available to perform the device, the elders in geracomium
  • •male and female
  • •aging 85 years or more

排除标准

  • •not available to perform the procedure
  • •untreated pneumothorax
  • •diffusion interstitial lung disease
  • •acute coronary syndrome
  • •third stage hypertension
  • •advanced cancer
  • •severe heart, liver, renal, blood system and endocrine system dysfunction
  • •noninvasive mechanical ventilation
  • •active hemoptysis

研究组 & 干预措施

control group

No Intervention

intervention

Experimental

Intervention group were given flutter valve mucus clearance devices to do pulmonary function exercise

干预措施: flutter mucus clearance device (Device)

结局指标

主要结局

FVC, Forced Vital Capacity

时间窗: up to 28 days

indicators of pulmonary function, for example, FVC(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

FEV1/FVC%, the Ratio of FEV1 to FVC

时间窗: up to 28 days

indicators of pulmonary function, All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher)

时间窗: up to 28 days

MPEF,Mean Peak Expiratory Flow

时间窗: up to 28 days

indicators of pulmonary function, for example, PEF(unit of measurement:Liter per minute) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

FEV1, Forced Expiratory Volume at First Second

时间窗: up to 28 days

indicators of pulmonary function, for example, FEV1(unit of measurement:Liter) All subjects sit upright in a chair and instructed to perform the pulmonary function test. Repeat the test until three reproducible acceptable results are obtained. Spirometry was performed at the first day of baseline and the 28th day of our study.

次要结局

  • Number of Cases With Antibiotics Therapy(up to 28 days)
  • Number of Cases With Hospital Visit(up to 28 days)

研究者

发起方
Tongji University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhang Xiangyu

MD, director, professor, FCCM, FCCP.

Tongji University

相似试验